Literature DB >> 8013750

Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM.

K S Polonsky1, B Gumbiner, D Ostrega, K Griver, H Tager, R R Henry.   

Abstract

Subjects with overt non-insulin-dependent diabetes mellitus (NIDDM) were studied in comparison to obese nondiabetic control subjects and patients with subclinical diabetes. Pancreatic insulin secretion rates were measured by deconvolution of peripheral C-peptide over a 24-h period while subjects consumed an isocaloric mixed diet. Subjects were then placed on caloric restriction for at least 6 weeks, during which time body weight fell by at least 10%. Refeeding with solid mixed meals was then resumed for at least 2 weeks until isocaloric intake was attained, and then the meal profiles were repeated. Before weight loss, insulin, C-peptide, and insulin secretion rates were significantly higher in subjects with subclinical diabetes than in the other two groups. Proinsulin concentrations were significantly greater in the two diabetic groups than in control subjects, but, when expressed as a percentage of the total insulin immunoreactivity, the differences were significant only in the group with overt diabetes. Weight loss because of hypocaloric feeding resulted in a significant increase in the rate of clearance of endogenously secreted insulin but did not affect the clearance of C-peptide. In obese subjects and those with subclinical diabetes, weight loss was associated with a reduction in insulin secretion rates, presumably as a result of improvements in insulin sensitivity. In patients with overt diabetes and hyperglycemia, weight loss improved beta-cell responsiveness to glucose and was associated with an increase in insulin clearance and a reduction in proinsulin immunoreactivity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8013750     DOI: 10.2337/diab.43.7.871

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  15 in total

Review 1.  The role of the liver in type 2 diabetes.

Authors:  Peter Staehr; Ole Hother-Nielsen; Henning Beck-Nielsen
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

Review 2.  Type 2 diabetes mellitus: a possible surgically reversible intestinal dysfunction.

Authors:  Priscila C Sala; Raquel S Torrinhas; Steven B Heymsfield; Dan L Waitzberg
Journal:  Obes Surg       Date:  2012-01       Impact factor: 4.129

3.  Ciliary neurotrophic factor (CNTF) protects non-obese Swiss mice against type 2 diabetes by increasing beta cell mass and reducing insulin clearance.

Authors:  L F Rezende; G J Santos; J C Santos-Silva; E M Carneiro; A C Boschero
Journal:  Diabetologia       Date:  2012-02-19       Impact factor: 10.122

4.  Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes.

Authors:  S R Kashyap; S Daud; K R Kelly; A Gastaldelli; H Win; S Brethauer; J P Kirwan; P R Schauer
Journal:  Int J Obes (Lond)       Date:  2009-12-22       Impact factor: 5.095

5.  Weight Loss as a Cure for Type 2 Diabetes? Fact or Fantasy.

Authors:  Sangeeta R Kashyap; Emily S Louis; John P Kirwan
Journal:  Expert Rev Endocrinol Metab       Date:  2011-07-01

6.  Components of metabolic syndrome and 5-year change in insulin clearance - the Insulin Resistance Atherosclerosis Study.

Authors:  C C Lee; C Lorenzo; S M Haffner; L E Wagenknecht; M O Goodarzi; D Stefanovski; J M Norris; M J Rewers; A J Hanley
Journal:  Diabetes Obes Metab       Date:  2013-01-21       Impact factor: 6.577

7.  Obesity and diabetes: the impact of bariatric surgery on type-2 diabetes.

Authors:  John B Dixon
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

8.  Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics.

Authors:  Jean-Pierre Le Floch
Journal:  Diabetes Metab Syndr Obes       Date:  2010-06-21       Impact factor: 3.168

9.  Adaptation of Insulin Clearance to Metabolic Demand Is a Key Determinant of Glucose Tolerance.

Authors:  Amalia Gastaldelli; Muhammad Abdul Ghani; Ralph A DeFronzo
Journal:  Diabetes       Date:  2020-10-19       Impact factor: 9.461

10.  Effect of gastrointestinal surgical manipulation on metabolic syndrome: a focus on metabolic surgery.

Authors:  Mario Rizzello; Francesco De Angelis; Fabio Cesare Campanile; Gianfranco Silecchia
Journal:  Gastroenterol Res Pract       Date:  2012-10-22       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.